Chris Langmead

(He/him)

1

Article

0

Comments

Chris Langmead is Professor, Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute of Pharmaceutical Sciences (MIPS), a collaborative venture targeting new medicines development for poorly-treated mental health disorders. He is also the co-founder and CEO of Phrenix Therapeutics, which is developing next-generation therapeutics for schizophrenia.

Experience

  • 2012–2023
    Professor & Deputy Director, Monash University
  • 2009–2012
    Head of Pharmacology, Heptares Therapeutics Ltd.
  • 1998–2009
    Team Leader, GSK

Contact Chris for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision